Editorial: Botulinum toxin in headache treatment: Finally a promising path?

Cephalalgia

Volumn 30, Issue 7, 2010, Pages 771-773

  Schoenen, Jean ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A; PLACEBO; TOPIRAMATE; BOTULINUM TOXIN; MUSCLE RELAXANT AGENT;

CHRONIC DAILY HEADACHE; CHRONIC TENSION HEADACHE; DRUG EFFICACY; EDITORIAL; HUMAN; THERAPY EFFECT; TRANSFORMED MIGRAINE; TREATMENT RESPONSE; HEADACHE; RANDOMIZED CONTROLLED TRIAL;

BOTULINUM TOXINS; HEADACHE; HUMANS; NEUROMUSCULAR AGENTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 78349256290     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1177/0333102410373154     Document Type: Editorial

References (8)

1. Evers S., Olesen J. Botulinum toxin in headache treatment: the end of the road. Cephalalgia 2006 ; 26: 769-771.
2. Delstanche S., Schoenen J. La toxine botulinique dans le traitement des cphales: Fin de route ou dbut d'un chemin? Neurone 2006 ; 11: 148-154.
3. Aurora SK, DW Dodick, Turkel CC et al. on behalf of PREEMPT 1 Chronic Migraine Study Group. Onabotulinum toxin A for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial. Cephalalgia 2010 17 March (DOI: 10.1177/0333102410364676).
4. Diener HC, Dodick DW, Aurora SK, et al. on behalf of the PREEMPT 2 Chronic Migraine Study Group. Onabotulinum toxin A for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial. Cephalalgia 2010 17 March (DOI: 10.1177/0333102410364677).
5. Olesen J., Bousser M-G., Diener H-C., et al. New appendix criteria open for a broader concept of chronic migraine. Cephalalgia 2006 ; 26: 742-746.
6. Manack A., Turkel C., Silberstein S. The evolution of chronic migraine: Classification and nomenclature. Headache 2009 ; 49: 1206-1213.
7. Silberstein S., Lipton R., Dodick D., et al. Topiramate treatment of chronic migraine: A randomized, placebo-controlled trial of quality of life and other efficacy measures. Headache 2009 ; 49: 1153-1162.
8. Mathew NT, Jaffri SFA. A double-blind comparison of Onabotulinum toxin A (BOTOX®) and topiramate (TOPAMAX®) for the prophylactic treatment of chronic migraine: A pilot study. Headache 2009 ; 49: 1466-1478.